Embolotherapy Market

Embolotherapy Market by Product (Embolic Agents (Microspheres, Detachable Coils, Pushable Coils), Guidewires), Disease (Oncology, Aneurysm, Peripheral Vascular), Procedure, End User (Hospitals, Clinics, ASC, Academia) - Global Forecast to 2024

[219 Pages Report] The embolotherapy market is projected to reach USD 4.9 billion by 2024 from USD 3.3 billion in 2019, at a CAGR of 8.1% from 2019 to 2024. Increasing incidences of peripheral vascular diseases, liver cancer, strokes, and uterine fibroids coupled with rising preference for minimally invasive procedures; increasing investments, funds, and grants by public-private organizations for research; and technological advancements in the market will fuel the market growth over the forecast period.

Embolotherapy Market

The microspheres segment accounted for the largest share of the embolotherapy market, by product, in 2018

Based on product, the market is broadly segmented into embolic agents and support devices. The embolic agents segment is further subsegmented into embolic coils, embolic plug systems, liquid embolic agents, microspheres, and detachable balloons. Whereas, the support devices segment includes microcatheters and guidewires. The microspheres segment under embolic agents held the largest share of the market in 2018. The market growth of this segment is majorly driven by the surge in the prevalence of hepatocellular carcinoma (microspheres are widely used to treat this disease), coupled with favorable reimbursement criteria in developed economies. Moreover, new product launches and approvals are further supporting the growth of this segment.

The disease indication segment, by cancer, to register significant growth over the forecast period

In terms of disease indication, embolotherapy market is classified into cancer, peripheral vascular diseases, neurological diseases, urological & nephrological disorders, and gastrointestinal disorders. The cancer segment commanded the largest share of the market in 2018, and the same segment will grow at the highest CAGR over the forecast period between 2019 and 2024. Rising incidences of liver cancer & kidney cancer coupled with respective adoption of TACE and TARE procedures, will support the market growth.

Transcatheter Arterial Embolization (TAE) procedure attributes to rising preference for minimally invasive surgeries

On the basis of procedure, the market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial chemoembolization (TACE), and transcatheter arterial radioembolization (TARE)/selective internal radiation therapy (SIRT). The increasing demand for minimally invasive procedures, growing prevalence of chronic diseases, and rapid growth in the geriatric population are some of the key factors contributing to the large share of the transcatheter arterial embolization segment.

The Hospitals and Clinics end user segment garnered the highest revenue in the embolotherapy market in 2018

Based on end user, the market is segmented into hospitals and clinics, ambulatory surgery centers (ASCs), and other end users. Hospitals and clinics are the key end users of embolotherapy devices. This segment covers the market for embolotherapy devices used in big hospitals, small clinics, and critical care units. The growing adoption of minimally invasive surgical procedures (including vascular, urological, and neurological), increasing purchasing power of major healthcare providers across developed countries (owing to the consolidation of healthcare providers), and the greater availability of reimbursements for target procedures in the US and major European countries are the major factors that are expected to drive the demand for embolization devices in hospitals and clinics.

The Asia Pacific market is expected to grow at the highest CAGR during the forecast period

The embolotherapy market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Improving healthcare infrastructure in the region, the large patient population for target diseases, and expanding presence of key market players in the region to grab elevating opportunities offered by these countries are the key factors supporting the market growth in this region.

Embolotherapy Market

Key Market Players

The major players in the market include Boston Scientific Corporation (US), Merit Medical Systems (US), Terumo Corporation (Japan), Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), BTG plc (UK), Penumbra, Inc. (US), Cook Medical (US), Abbott Laboratories (US), Acandis GmbH (Germany), BALT Extrusion (France), Sirtex Medical Limited (Australia), Kaneka Corporation (Japan), and Meril Life Sciences Pvt. Ltd. (India) among others.

An analysis of the market developments between 2016 and 2019 revealed that several growth strategies such as product launches and enhancements, partnerships, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the embolotherapy market. Among these business strategies, partnerships and agreements were the most widely adopted growth strategies by market players.

Boston Scientific Corporation (US) is one of the key players operating in the global market. The company offers modalities in all product segments of market. Various organic growth strategies, like product launches & approvals and inorganic growth strategies, such as acquisitions and collaborations, were adopted by the company in order to expand its presence and market share. For instance, in 2019, the company acquired BTG Plc (UK). This acquisition expanded Boston’s peripheral interventions portfolio with minimally invasive treatments for cancer and vascular conditions. Moreover, in 2015, Boston acquired the interventional radiology portfolio of CeloNova BioSciences (US).

Scope of the Report

Report Metric

Details

Market Size Available for Years

2017–2024

Base Year Considered

2018

Forecast Period

2019–2024

Forecast Units

Value (USD)

Segments Covered

Product, Disease Indication, Procedure, End User, and Region

Geographies Covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Companies Covered

The major players in the market include Boston Scientific Corporation (US), Merit Medical Systems (US), Terumo Corporation (Japan), Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), BTG plc (UK), Penumbra, Inc. (US), Cook Medical (US), Abbott Laboratories (US), Acandis GmbH (Germany), BALT Extrusion (France), Sirtex Medical Limited (Australia), Kaneka Corporation (Japan), and Meril Life Sciences Pvt. Ltd. (India) among others.

This research report categorizes the market, by product, disease indication, procedure, end user, and region.

Embolotherapy Market, by Product

  • Embolic agents
  • Microspheres
  • Embolic coils
    • Detachable Coils
    • Pushable Coils
  • Liquid Embolic Agents
  • Embolic Plug Systems
  • Detachable Balloons
  • Support Devices
  • Microcatheters
  • Guidewires

Embolotherapy Market, by Disease Indication

  • Cancer
  • Liver Cancer
  • Kidney Cancer
  • Other Cancers
  • Peripheral Vascular Diseases
  • Neurological Diseases
  • Cerebral Aneurysm
  • Cerebral Arteriovenous Malformations and Fistulas
  • Gastrointestinal Disorders
  • Urological and Nephrological Disorders

Embolotherapy Market, by Procedure

  • Transcatheter Arterial Embolization
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
  • Transarterial Chemoembolization

Embolotherapy Market, by End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Other End Users

Embolotherapy Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • RoE
  • Asia Pacific
    • China
    • Japan
    • India
    • RoAPAC
  • Latin America
    • Brazil
    • RoLA
  • The Middle East and Africa

Recent Developments:

  • In 2019, MicroVention, Inc., a US-based subsidiary of Terumo Corporation (Japan) received FDA Premarket Approval (PMA) for the ‘WEB Aneurysm Embolization System’ for the treatment of intracranial wide-neck bifurcation aneurysms
  • In 2019, Terumo Corporation (Japan) received CE mark approval for its QuiremScout microsphere for advanced SIRT work-up procedure
  • In 2019, Boston Scientific Corporation (US) acquired BTG Plc (UK). The acquisition expanded Boston’s peripheral interventions portfolio with minimally invasive treatments for cancers and vascular conditions.
  • In 2018, Medtronic (Ireland) launched OptiSphere embolization spheres in the US as well as Concerto 3D detachable coil system in Ireland
  • In 2018, Cerenovus division of Johnson & Johnson (US) launched its Galaxy G3 mini coil for use in the endovascular treatment of cerebral aneurysms and hemorrhagic stroke

Key Questions Addressed by the Report:

  • What are the growth opportunities related to the adoption of embolotherapy devices across the globe in the future?
  • Which product will register the highest adoption rate during the forecast period?
  • Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
  • Emerging countries have immense opportunities for the growth and adoption of interventional oncology and interventional radiology procedures. Will this scenario continue in the next five years?
  • Which end users are estimated to adopt embolotherapy products?
  • What are the key strategies adopted by the key players operating in the market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 20)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 24)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Product-Based Market Estimation
           2.2.2 Primary Research Validation
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions
    2.5 Research Limitations

3 Executive Summary (Page No. - 35)

4 Premium Insights (Page No. - 39)
    4.1 Embolotherapy: Market Overview
    4.2 Embolotherapy Market, By Product
    4.3 Market, By Procedure and Region
    4.4 Market, By Disease Indication
    4.5 Asia Pacific Market, By End User aand Country
    4.6 Geographic Snapshot of the Market

5 Market Overview (Page No. - 45)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Growing Target Patient Population
                    5.2.1.2 Rising Patient Preference for Minimally Invasive Procedures
                    5.2.1.3 Funding & Investments By Government and Private Organizations
                    5.2.1.4 Technological Advancements in Embolotherapy Devices
                    5.2.1.5 Favorable Reimbursement Scenario for Minimally Invasive Surgeries
           5.2.2 Restraints
                    5.2.2.1 Lack of Sufficient Evidence & Unfavorable Regulatory Scenario
                    5.2.2.2 Strong Market Positioning of Alternative Therapies
           5.2.3 Opportunities
                    5.2.3.1 Growth Opportunities Offered By Emerging Markets
                    5.2.3.2 Expanding Applications of Embolization Devices
           5.2.4 Challenges
                    5.2.4.1 Dearth of Skilled Surgeons
                    5.2.4.2 High Costs and Resulting Difficulties in Accessing Embolization in Developing Countries

6 Embolotherapy Market, By Product (Page No. - 54)
    6.1 Introduction
    6.2 Embolic Agents
           6.2.1 Microspheres
                    6.2.1.1 Preference for Alternative Procedures Limits the Growth of This Market Segment
           6.2.2 Embolic Coils
                    6.2.2.1 Detachable Coils
                               6.2.2.1.1 Detachable Coils Can Be Retracted and Redeployed A Number of Times Until Satisfactory Placement is Reached, Which is A Key Advantage of This Product Segment
                    6.2.2.2 Pushable Coils
                               6.2.2.2.1 Use of Pushable Coils Increases the Risk of Non-Target Vascular Blockages, Thereby Hampering Their Use in Various Applications
           6.2.3 Liquid Embolic Agents
                    6.2.3.1 Significant Adoption of Embolic Coils Due to Their Procedural Benefits Over Liquid Embolic Agents is Expected to Restrict Market Growth
           6.2.4 Embolic Plug Systems
                    6.2.4.1 Procedural Advantages Delivered By Vascular Plugs Such as A Significantly Shorter Occlusion Time and Recanalization Rate are the Key Factors Leading to Their Increased Adoption
           6.2.5 Detachable Balloons
                    6.2.5.1 Adverse Events Associated With the Use of Detachable Balloons Such as Balloon Rupture, Failure, Or Shrinkage May Limit the Utilization of This Embolic Device
    6.3 Support Devices
           6.3.1 Microcatheters
                    6.3.1.1 Advancements and Regulatory Approvals in Microcatheter Technologies are Expected to Result in Their Wider Adoption
           6.3.2 Guidewires
                    6.3.2.1 Rising Adoption of Guidewires Among Medical Professionals Owing to Their Procedural Benefits is Expected to Drive Market Growth

7 Embolotherapy Market, By Disease Indication (Page No. - 70)
    7.1 Introduction
    7.2 Cancer
           7.2.1 Liver Cancer
                    7.2.1.1 Rising Prevalence of Liver Cancer is Projected to Fuel Segment Growth
           7.2.2 Kidney Cancer
                    7.2.2.1 The Wide Adoption of Preoperative Kidney Tumor Embolization in the Treatment of Kidney Cancer is Driving Market Growth
           7.2.3 Other Cancers
                    7.2.3.1 Increasing Clinical Research to Check the Effectiveness of Embolization for Cancer Treatment to Drive Market Growth
    7.3 Peripheral Vascular Disease
           7.3.1 Rising Adoption of Vascular Plugs is A Key Driving Factor for the Market
    7.4 Neurological Diseases
           7.4.1 Cerebral Aneurysm
                    7.4.1.1 Limited Availability of Reimbursements Across Major Markets May Hinder Market Growth
           7.4.2 Arteriovenous Malformation and Fistulas
                    7.4.2.1 Side Effects Associated With AVM Embolization Procedures May Restrict Market Growth to A Certain Extent
    7.5 Urological & Nephrological Disorders
           7.5.1 Embolic Agents are Used to Treat Uterine Fibroids, Autosomal Dominant Polycystic Kidney Disease, and Benign Prostatic Hyperplasia
    7.6 Gastrointestinal Disorders
           7.6.1 Embolization is A Widely Adopted Procedure Used to Treat LGIB and LGIB

8 Embolotherapy Market, By Procedure (Page No. - 83)
    8.1 Introduction
    8.2 Transcatheter Arterial Embolization (TAE)
           8.2.1 Transcatheter Arterial Embolization Dominates the Market Due to the Increasing Incidence of Uterine Fibroids & Vascular Lesions
    8.3 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
           8.3.1 Better Clinical Outcomes & Increased Cancer Survival Rate are Supporting the Growth of This Segment
    8.4 Transarterial Chemoembolization (TACE)
           8.4.1 TACE Can Be Used to Treat Tumors That are Relatively Larger in Size, Which Cannot Be Easily Treated By Tumor Ablation

9 Embolotherapy Market, By End User (Page No. - 89)
    9.1 Introduction
    9.2 Hospitals and Clinics
    9.3 Ambulatory Surgery Centers
    9.4 Other End Users

10 Embolotherapy Market, By Region (Page No. - 94)
     10.1 Introduction
     10.2 North America
             10.2.1 US
                        10.2.1.1 The US Dominates the Global Market in 2018 Due to the Large R&D Investments in the Country
             10.2.2 Canada
                        10.2.2.1 High Burden of Cancer to Support Market Growth
     10.3 Europe
             10.3.1 Germany
                        10.3.1.1 Germany is the Fastest-Growing Market in Europe
             10.3.2 UK
                        10.3.2.1 Increasing Incidence of Target Health Conditions Coupled With the Rising Geriatric Population to Drive Market Growth
             10.3.3 France
                        10.3.3.1 Government Initiatives to Raise Awareness About Embolotherapy Will Increase the Adoption of Embolization Procedures in the Country
             10.3.4 Rest of Europe
     10.4 Asia Pacific
             10.4.1 Japan
                        10.4.1.1 Growing Geriatric Population and the Increasing R&D Investments in the Country are the Major Factors Driving Market Growth
             10.4.2 China
                        10.4.2.1 China to Register the Highest Growth in the APAC Embolotherapy Market Due to the Growing Target Patient Population
             10.4.3 India
                        10.4.3.1 Ongoing Modernization and Expansion of Healthcare Infrastructure and Growing Medical Tourism to Support Market Growth
             10.4.4 Rest of Asia Pacific
     10.5 Latin America
             10.5.1 Brazil
                        10.5.1.1 Increasing Incidence of Hepatocellular Carcinoma and Cerebral Aneurysm to Drive the Adoption of Embolization Products
             10.5.2 Rest of Latin America
     10.6 Middle East & Africa

11 Competitive Landscape (Page No. - 173)
     11.1 Introduction
     11.2 Market Share Analysis
             11.2.1 Market Share Analysis for Microspheres (2018)
             11.2.2 Market Share Analysis for Embolization Coils (2018)
     11.3 Competitive Situation and Trends
     11.4 Competitive Leadership Mapping
     11.5 Vendor Inclusion Criteria
     11.6 Vendor Dive
             11.6.1 Visionary Leaders
             11.6.2 Innovators
             11.6.3 Dynamic Differentiators
             11.6.4 Emerging Players

12 Company Profiles (Page No. - 180)
     12.1 Abbott Laboratories
     12.2 Acandis GmbH
     12.3 Balt Extrusion
     12.4 Boston Scientific Corporation
     12.5 BTG PLC
     12.6 Cook Medical
     12.7 Johnson & Johnson
     12.8 Kaneka Corporation
     12.9 Medtronic PLC
     12.10 Meril Life Sciences Pvt., Ltd.
     12.11 Merit Medical Systems
     12.12 Penumbra, Inc.
     12.13 Sirtex Medical Limited
     12.14 Stryker Corporation
     12.15 Terumo Corporation

13 Appendix (Page No. - 210)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Available Customizations
     13.4 Related Reports
     13.5 Author Details


List of Tables (184 Tables)

Table 1 Primary Liver Cancer Incidence Among Men and Women (2005 vs 2030)
Table 2 Geriatric Population, By Region, 2015 vs 2030
Table 3 Medical Reimbursement Cpt Codes for Embolization Procedures in the US (Effective From January 2019)
Table 4 Medical Reimbursement Ms-Drg Codes for Embolization Procedures in the US (Effective From January 2019)
Table 5 Embolotherapy Market, By Product, 2017–2024 (USD Million)
Table 6 Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 7 Market for Embolic Agents, By Region, 2017–2024 (USD Million)
Table 8 Embolic Agents, By Type
Table 9 Market for Microspheres, By Region, 2017–2024 (USD Million)
Table 10 Embolic Coils Offered By Major Market Players
Table 11 Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 12 Market for Embolic Coils, By Region, 2017–2024 (USD Million)
Table 13 Market for Detachable Coils, By Region, 2017–2024 (USD Million)
Table 14 Market for Pushable Coils, By Region, 2017–2024 (USD Million)
Table 15 Embolotherapy Market for Liquid Embolic Agents, By Region, 2017–2024 (USD Million)
Table 16 Market for Embolic Plug Systems, By Region, 2017–2024 (USD Million)
Table 17 Market for Detachable Balloons, By Region, 2017–2024 (USD Million)
Table 18 Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 19 Market for Support Devices, By Region, 2017–2024 (USD Million)
Table 20 Market for Microcatheters, By Region, 2017–2024 (USD Million)
Table 21 Market for Guidewires, By Region, 2017–2024 (USD Million)
Table 22 Market, By Disease Indication, 2017–2024
Table 23 Embolotherapy Market for Cancer, By Type, 2017–2024
Table 24 Market for Cancer, By Region, 2017–2024
Table 25 Market for Liver Cancer, By Region, 2017–2024 (USD Million)
Table 26 Market for Kidney Cancer, By Region, 2017–2024 (USD Million)
Table 27 Market for Other Cancers, By Region, 2017–2024 (USD Million)
Table 28 Market for Peripheral Vascular Diseases, By Region, 2017–2024 (USD Million)
Table 29 Embolotherapy Market for Neurological Diseases, By Type, 2017–2024
Table 30 Market for Neurological Diseases, By Region, 2017–2024 (USD Million)
Table 31 Market for Cerebral Aneurysms, By Region, 2017–2024 (USD Million)
Table 32 Market for Arteriovenous Malformation & Fistulas, By Region, 2017–2024 (USD Million)
Table 33 Market for Urological & Nephrological Diseases, By Region, 2017–2024 (USD Million)
Table 34 Market for Gastrointestinal Disorders, By Region, 2017–2024 (USD Million)
Table 35 Embolotherapy Market, By Procedure, 2017–2024 (USD Million)
Table 36 Transcatheter Arterial Embolization Market, By Region, 2017–2024 (USD Million)
Table 37 Transcatheter Arterial Radioembolization Market, By Region, 2017–2024 (USD Million)
Table 38 Transarterial Chemoembolization Market, By Region, 2017–2024
Table 39 Market, By End User, 2017–2024 (USD Million)
Table 40 Market for Hospitals and Clinics, By Region, 2017–2024 (USD Million)
Table 41 Market for Ambulatory Surgery Centers, By Region, 2017–2024 (USD Million)
Table 42 Embolotherapy Market for Other End Users, By Region, 2017–2024 (USD Million)
Table 43 Market, By Region, 2017–2024 (USD Million)
Table 44 North America: Market, By Country, 2017–2024 (USD Million)
Table 45 North America: Market, By Product, 2017–2024 (USD Million)
Table 46 North America: Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 47 North America: Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 48 North America: Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 49 North America: Market, By Disease Indication, 2017–2024 (USD Million)
Table 50 North America: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 51 North America: Market for Neurological Diseases, By Type, 2017–2024 (USD Million)
Table 52 North America: Market, By Procedure, 2017–2024 (USD Million)
Table 53 North America: Market, By End User, 2017–2024 (USD Million)
Table 54 Medicare Reimbursement for Transcatheter Embolization Or Occlusion Services: 2019
Table 55 US: Market, By Product, 2017–2024 (USD Million)
Table 56 US: Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 57 US: Embolotherapy Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 58 US: Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 59 US: Market, By Disease Indication, 2017–2024 (USD Million)
Table 60 US: Market, By Procedure, 2017–2024 (USD Million)
Table 61 US: Market, By End User, 2017–2024 (USD Million)
Table 62 Canada: Market, By Product, 2017–2024 (USD Million)
Table 63 Canada: Embolotherapy Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 64 Canada: Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 65 Canada: Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 66 Canada: Market, By Disease Indication, 2017–2024 (USD Million)
Table 67 Canada: Market, By Procedure, 2017–2024 (USD Million)
Table 68 Canada: Market, By End User, 2017–2024 (USD Million)
Table 69 Europe: Market, By Country, 2017–2024 (USD Million)
Table 70 Europe: Market, By Product, 2017–2024 (USD Million)
Table 71 Europe: Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 72 Europe: Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 73 Europe: Embolotherapy Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 74 Europe: Market, By Disease Indication, 2017–2024 (USD Million)
Table 75 Europe: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 76 Europe: Market for Neurological Diseases, By Type, 2017–2024 (USD Million)
Table 77 Europe: Market, By Procedure, 2017–2024 (USD Million)
Table 78 Europe: Market, By End User, 2017–2024 (USD Million)
Table 79 Germany: Embolotherapy Market, By Product, 2017–2024 (USD Million)
Table 80 Germany: Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 81 Germany: Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 82 Germany: Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 83 Germany: Market, By Disease Indication, 2017–2024 (USD Million)
Table 84 Germany: Market, By Procedure, 2017–2024 (USD Million)
Table 85 Germany: Market, By End User, 2017–2024 (USD Million)
Table 86 UK: Embolotherapy Market, By Product, 2017–2024 (USD Million)
Table 87 UK: Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 88 UK: Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 89 UK: Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 90 UK: Market, By Disease Indication, 2017–2024 (USD Million)
Table 91 UK: Market, By Procedure, 2017–2024 (USD Million)
Table 92 UK: Market, By End User, 2017–2024 (USD Million)
Table 93 France: Market, By Product, 2017–2024 (USD Million)
Table 94 France: Embolotherapy Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 95 France: Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 96 France: Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 97 France: Market, By Disease Indication, 2017–2024 (USD Million)
Table 98 France: Market, By Procedure, 2017–2024 (USD Million)
Table 99 France: Market, By End User, 2017–2024 (USD Million)
Table 100 RoE: Health Expenditure, By Country (2017)
Table 101 Aging Population (% Share of the Total Population), By Country, 2015 vs 2030 (In Million)
Table 102 Cancer Incidence, By Country, 2018
Table 103 RoE: Embolotherapy Market, By Product, 2017–2024 (USD Million)
Table 104 RoE: Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 105 RoE: Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 106 RoE: Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 107 RoE: Market, By Disease Indication, 2017–2024 (USD Million)
Table 108 RoE: Market, By Procedure, 2017–2024 (USD Million)
Table 109 RoE: Market, By End User, 2017–2024 (USD Million)
Table 110 Asia Pacific: Embolotherapy Market, By Country, 2017–2024 (USD Million)
Table 111 Asia Pacific: Market, By Product, 2017–2024 (USD Million)
Table 112 Asia Pacific: Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 113 Asia Pacific: Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 114 Asia Pacific: Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 115 Asia Pacific: Market, By Disease Indication, 2017–2024 (USD Million)
Table 116 Asia Pacific: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 117 Asia Pacific: Embolotherapy Market for Neurological Diseases, By Type, 2017–2024 (USD Million)
Table 118 Asia Pacific: Market, By Procedure, 2017–2024 (USD Million)
Table 119 Asia Pacific: Market, By End User, 2017–2024 (USD Million)
Table 120 Japan: Market, By Product, 2017–2024 (USD Million)
Table 121 Japan: Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 122 Japan: Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 123 Japan: Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 124 Japan: Embolotherapy Market, By Disease Indication, 2017–2024 (USD Million)
Table 125 Japan: Market, By Procedure, 2017–2024 (USD Million)
Table 126 Japan: Market, By End User, 2017–2024 (USD Million)
Table 127 China: Market, By Product, 2017–2024 (USD Million)
Table 128 China: Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 129 China: Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 130 China: Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 131 China: Embolotherapy Market, By Disease Indication, 2017–2024 (USD Million)
Table 132 China: Market, By Procedure, 2017–2024 (USD Million)
Table 133 China: Market, By End User, 2017–2024 (USD Million)
Table 134 India: Market, By Product, 2017–2024 (USD Million)
Table 135 India: Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 136 India: Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 137 India: Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 138 India: Embolotherapy Market, By Disease Indication, 2017–2024 (USD Million)
Table 139 India: Market, By Procedure, 2017–2024 (USD Million)
Table 140 India: Market, By End User, 2017–2024 (USD Million)
Table 141 RoAPAC: Market, By Product, 2017–2024 (USD Million)
Table 142 RoAPAC: Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 143 RoAPAC: Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 144 RoAPAC: Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 145 RoAPAC: Embolotherapy Market, By Disease Indication, 2017–2024 (USD Million)
Table 146 RoAPAC: Market, By Procedure, 2017–2024 (USD Million)
Table 147 RoAPAC: Market, By End User, 2017–2024 (USD Million)
Table 148 Latin America: Market, By Country, 2017–2024 (USD Million)
Table 149 Latin America: Market, By Product, 2017–2024 (USD Million)
Table 150 Latin America: Embolotherapy Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 151 Latin America: Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 152 Latin America: Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 153 Latin America: Market, By Disease Indication, 2017–2024 (USD Million)
Table 154 Latin America: Embolotherapy Market for Cancer, By Type, 2017–2024 (USD Million)
Table 155 Latin America: Market for Neurological Diseases, By Type, 2017–2024 (USD Million)
Table 156 Latin America: Market, By Procedure, 2017–2024 (USD Million)
Table 157 Latin America: Market, By End User, 2017–2024 (USD Million)
Table 158 Brazil: Market, By Product, 2017–2024 (USD Million)
Table 159 Brazil: Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 160 Brazil: Embolotherapy Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 161 Brazil: Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 162 Brazil: Market, By Disease Indication, 2017–2024 (USD Million)
Table 163 Brazil: Market, By Procedure, 2017–2024 (USD Million)
Table 164 Brazil: Embolotherapy Market, By End User, 2017–2024 (USD Million)
Table 165 RoLA: Market, By Product, 2017–2024 (USD Million)
Table 166 RoLA: Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 167 RoLA: Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 168 RoLA: Embolotherapy Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 169 RoLA: Market, By Disease Indication, 2017–2024 (USD Million)
Table 170 RoLA: Embolotherapy Market, By Procedure, 2017–2024 (USD Million)
Table 171 RoLA: Market, By End User, 2017–2024 (USD Million)
Table 172 Middle East & Africa: Market, By Product, 2017–2024 (USD Million)
Table 173 Middle East & Africa: Market for Embolic Agents, By Type, 2017–2024 (USD Million)
Table 174 Middle East & Africa: Embolotherapy Market for Embolic Coils, By Type, 2017–2024 (USD Million)
Table 175 Middle East & Africa: Market for Support Devices, By Type, 2017–2024 (USD Million)
Table 176 Middle East & Africa: Market, By Disease Indication, 2017–2024 (USD Million)
Table 177 Middle East & Africa: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 178 Middle East & Africa: Market for Neurological Diseases, By Type, 2017–2024 (USD Million)
Table 179 Middle East & Africa: Market, By Procedure, 2017–2024 (USD Million)
Table 180 Middle East & Africa: Embolotherapy Market, By End User, 2017–2024 (USD Million)
Table 181 Product Launches and Approvals
Table 182 Collaborations
Table 183 Expansions
Table 184 Acquisitions


List of Figures (37 Figures)

Figure 1 Embolotherapy Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primaries: Market
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Bottom-Up Approach Market Size Estimation: Market
Figure 6 Top-Down Approach Market Size Estimation: Embolotherapy Market
Figure 7 Data Triangulation Methodology
Figure 8 Market, By Product, 2019–2024 (USD Million)
Figure 9 Market Share, By Disease Indication, 2019 vs 2024
Figure 10 Market Share, By Procedure, 2019–2024 (USD Million)
Figure 11 Market, By End User, 2019–2024 (USD Million)
Figure 12 Embolotherapy Market, By Region: Geographical Snapshot
Figure 13 Rising Incidence of Chronic Diseases is Driving the Growth of the Embolotherapy Market Across the Globe
Figure 14 Microspheres Segment Will Witness High Growth in the Market
Figure 15 Transcatheter Arterial Embolization Segment to Dominate the North American Market in 2019
Figure 16 Cancer Segment to Dominate the Market During the Forecast Period
Figure 17 Ambulatory Surgery Centers Segment Will Register the Highest CAGR in Asia Pacific
Figure 18 China to Register the Highest CAGR During the Forecast Period
Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 North America: Market Snapshot
Figure 21 Europe: Embolotherapy Market Snapshot
Figure 22 Asia Pacific: Market Snapshot
Figure 23 Key Developments in the Market From 2015 to 2019
Figure 24 BTG PLC Accounted for the Largest Share of the Microspheres Market in 2018
Figure 25 Stryker Held the Leading Position of the Embolization Coils Market in 2018
Figure 26 Market:Global Competitive Leadership Mapping, 2018
Figure 27 Abbott Laboratories: Company Snapshot
Figure 28 Boston Scientific Corporation: Company Snapshot
Figure 29 BTG PLC: Company Snapshot
Figure 30 Johnson & Johnson: Company Snapshot
Figure 31 Kaneka Corporation: Company Snapshot
Figure 32 Medtronic PLC: Company Snapshot
Figure 33 Merit Medical Systems: Company Snapshot
Figure 34 Penumbra, Inc.: Company Snapshot
Figure 35 Sirtex Medical Limited: Company Snapshot
Figure 36 Stryker Corporation: Company Snapshot
Figure 37 Terumo Corporation: Company Snapshot

The study involved four major activities to estimate the current size of the embolotherapy market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of the segments and subsegments.

Secondary Research

This research study involved the extensive use of secondary sources, directories, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva), along with government databases, which were used to identify and collect information for this method-based, market-oriented, and commercial study of the embolotherapy market.

In-depth interviews were conducted with various primary respondents that mainly include key industry participants, medical practitioners, subject-matter experts (SMEs), C-level and D-level executives of key market players, and industry consultants to obtain and verify critical qualitative and quantitative information as well as to assess prospects of the market.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the market scenario through secondary research. A significant number of primary interviews were conducted with both the demand (healthcare providers, research institutes, physicians, and healthcare professionals) and supply sides (developers, manufacturers, and distributors of embolotherapy products). The primaries interviewed for this study include experts from the interventional radiology, interventional oncology, interventional neurology, and embolotherapy devices industry (such as CEOs, VPs, directors, sales heads, and marketing managers of tier 1, 2, and 3 companies engaged in offering embolotherapy products across the globe) and administrators & purchase managers of hospitals, radiologists oncologists, neurologists, outpatient centers, and healthcare service providers.

Around 60% and 40% primary interviews were conducted with the supply and demand sides, respectively. A robust primary research methodology has been adopted to validate the contents of the report and to fill gaps. Telephonic and e-mail communications were adopted to conduct interviews (questionnaires were designed and sent to primary participants as per their convenience). The following is the breakdown of primary respondents:

Embolotherapy Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

A detailed market estimation approach was followed to estimate and validate the size of the embolotherapy market and other dependent submarkets, as mentioned above. The key players in the market were identified through secondary research, and their market shares in the respective countries were determined through primary and secondary research. The research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights (both quantitative and qualitative trends) on the market. All percentage shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources. All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets, and presented in this report. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size of the embolotherapy industry from the market estimation approach explained above, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact market value data, data triangulation and market breakdown methodology methods were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand- and supply-side analysis.

Report Objectives

  • To define, describe, and forecast the embolotherapy market on the basis of product, disease indication, procedure, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the revenue of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • To strategically profile the key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as new product launches; agreements, partnerships, and joint ventures; mergers & acquisitions; business expansions and research & development activities in the embolotherapy market          

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present market report:

Product Analysis

Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Report Code
MD 7279
Published ON
Aug, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Embolotherapy Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home